OverviewChartTechnicalNewsTraderScreen

Pieris Pharmaceuticals Inc/  US7207952026  /

NASDAQ
2024-09-26  9:59:52 PM Chg. -0.3300 Volume Bid10:00:02 PM Ask10:00:02 PM High Low
16.1600USD -2.00% 8,323
Turnover: 102,946.0523		 15.4000Bid Size: 1,400 19.4700Ask Size: 100 17.0000 16.1600
GlobeNewswire 08-17 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AFBI, ENV, PIRS, BALY on Behalf of Sharehol...
GlobeNewswire 08-16 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates K and PIRS on Behalf of Shareholders
GlobeNewswire 08-13 SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Pieris Pharmaceutica...
GlobeNewswire 07-08 Avacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of ...
GlobeNewswire 01-05 Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
GlobeNewswire 2022-01-28 HTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of Directors
GlobeNewswire 2021-11-11 Aerami Therapeutics Appoints Darlene Deptula-Hicks to its Board of Directors
GlobeNewswire 2021-08-23 Connect Biopharma Hires General Counsel & Chief Compliance Officer and Appoints a New Board Member
GlobeNewswire 2021-03-18 Trillium Therapeutics Reports Annual Operating and Financial Results and Sets Date for R&D Day
GlobeNewswire 2020-11-02 Trillium Therapeutics Appoints Dr. Ingmar Bruns as Chief Medical Officer
GlobeNewswire 2020-07-09 ImCheck Therapeutics Appoints Claude Knopf as Chief Business Officer
GlobeNewswire 2019-06-21 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market 2019
GlobeNewswire 2019-04-10 New Research Coverage Highlights Fortive, Pieris Pharmaceuticals, CEVA, ManTech International, Cerus...
GlobeNewswire 2019-02-26 Factors of Influence in 2019, Key Indicators and Opportunity within Conagra Brands, Pieris Pharmaceu...
GlobeNewswire 2018-12-17 Chronic Respiratory Disease Drug Development Pipeline Review, 2018: Therapeutics Under Development a...
GlobeNewswire 2018-11-07 Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
GlobeNewswire 2018-10-31 Pieris Pharmaceuticals to Host Third Quarter 2018 Investor Call and Corporate Update on November 7, ...
GlobeNewswire 2018-09-25 Pieris Pharmaceuticals to Present at Investor Conferences in October
GlobeNewswire 2018-09-14 Pieris Pharmaceuticals to Present Preclinical Data for Inhaled IL-4Rα Antagonist AZD1402/PRS-060 at ...
GlobeNewswire 2018-09-10 Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil. to its Board of Directors
GlobeNewswire 2018-09-04 Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Pl...
GlobeNewswire 2018-08-30 Pieris Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
GlobeNewswire 2018-08-15 New Research Coverage Highlights Cincinnati Bell, BioCryst Pharmaceuticals, Shutterstock, Kopin, Lan...
GlobeNewswire 2018-08-10 Novel Drugs and Smart Devices for Respiratory Disorders, 2030 - Focus on Asthma, COPD and Cystic Fib...
GlobeNewswire 2018-08-09 Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update